65,437 trials
Hip Fractures
Primary: Evaluation of the Analgesic Efficacy of Both Local Anesthetics in the Regional Block of Hip Fracture Surgery — 10; 4; 12; 14 Participants
Dengue Fever · Dengue Hemorrhagic Fever · Human Immunodeficiency Virus
Primary: Percentage of Participants With Unsolicited Systemic Adverse Event (AE) — 0; 0 percentage of participants
Enterovirus Infection · Type 1 Diabetes · Prediabetic State
Primary: Number of Participants With the Appearance of Type 1 Diabetes Associated Auto-antibodies in Serum — 17; 2 Participants
Pediatric Obesity
Primary: Change in β-carotene — .127; .116; .224; .107 ug/mL
Hypertension
Primary: In-clinic Blood Pressure Change — 136.0; 140.3; 126.9; 136.1 mm Hg — p=0.72
Virus Diseases · Rabies
Primary: Number of Participants Reporting Serious Adverse Events (SAEs) After a Booster Dose of Purified Chick Embryo Cell Culture (PCEC) Rabies Vaccine — 2; 0; 3 Participants
B-Cell Prolymphocytic Leukemia · Chronic Lymphocytic Leukemia · Peripheral T-Cell Lymphoma
Primary: Cytomegalovirus (CMV) Reactivation
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glucose Area Under the Plasma Concentration Versus Time Curve From Zero to 4 Hours Post-dose AUC(0-4) — -190.0296; -182.7172; -57.0768; -40.6842…
PTSD
Primary: Clinician Administered PTSD Scale for Diagnostic (CAPS-5) and Statistical Manual of Mental Disorders (DSM-5) — 26.17; 24.78 CAPS-5 total score
Advanced Solid Tumor · Lymphoma
Primary: Number of Participants With Treatment-emergent Adverse Events (≥10% Overall) in Participants Receiving Milademetan — 3; 1; 1; 33 Participants
Oesophageal Adenocarcinoma · Squamous Cell Carcinoma · Solid Tumor
Primary: STAGE A1 - Number of Dose Limiting Toxicities for M6620 (Berzosertib) Administered Concomitantly With Radiotherapy (RT) in the Palliative Treatment of Oesophageal…
Lung Cancer · Non-Small Cell Lung Cancer
Primary: Number of Non-HBV Participants Experiencing High Grade Treatment-Related Select Adverse Events — 2; 8; 5; 2 Participants
Communication · Patient Satisfaction
Primary: Number of Participants With a Positive Response Score of 4 to Question 1 on the Clinician & Group Survey-Consumer Assessment of Healthcare Providers and Systems…
Stroke · Depression · Anxiety
Primary: Stroke Specific Quality of Life Scale Change — 41.24; 41.67 units on a scale
Vitamin D Deficiency
Primary: Serum-vitamin D — 19.7; 34.4; 38.7; 58.7 25(OH)D, nmol/L — p=0.001